Improving Pregnancy Rates After Intracytoplasmic Sperm Injection by Using MIFT Technique : A New Option for Embryo Transfer

Authors

  • Suwit Suppinyopong Department of Gynecology and Obstetrics, Faculty of Medicine Siriraj Hospita, Mahidol University, Bangkok, Thailand
  • Chailai Khlaikhrua Department of Gynecology and Obstetrics, Faculty of Medicine Siriraj Hospita, Mahidol University, Bangkok, Thailand
  • Charunee Karavakul Department of Gynecology and Obstetrics, Faculty of Medicine Siriraj Hospita, Mahidol University, Bangkok, Thailand

Keywords:

Pregnancy, Intracytoplasmic Sperm, Injection, MIFT Technique

Abstract

evaluate the efficacy of a new technique, micro-injected oocytes intrafallopian transfer (MIFT), involving a same day procedure. 9 patients with at least one patient fallopian tube were offered this procedure. Ovarian induction consisted of down regulation with GnRHa followed by ovarian stimulation with hMG except for one patient who received only hMG due to a poor response. HCG 10,000 IU was administered when at least 2 leading follicles exceeded 18 mm. in diameter and transvaginal oocyte retrieval was performed 34-36 hours thereafter. Intracytoplasmic sperm injection (ICSI) was performed on the oocytes of all patients with male factor infertility. MIFT was performed on the same day after ICSI by transferring 2-5 micro-injected oocytes into the fallopian tube by laparoscopy under general anesthesia. The implantation rate and pregnancy rate were 16.1% (5/31) and 55.6% (5/9) respectively. This study suggests that MIFT is effective, easy and should be considered as a new option which yields a high pregnancy rate.

Downloads

Published

11-08-2020

How to Cite

Suppinyopong, S. ., Khlaikhrua, C. ., & Karavakul, C. . (2020). Improving Pregnancy Rates After Intracytoplasmic Sperm Injection by Using MIFT Technique : A New Option for Embryo Transfer. Siriraj Medical Journal, 53(1), 22–26. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/244050

Issue

Vol. 53 No. 1 (2001): January

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.